BioVie Stock Forecast

Stock Price Forecast

According to 2 analysts polled by S&P Global, BioVie stock has a consensus rating of "Strong Buy" and an average price target of $5.26. The average 1-year stock price forecast is 143.52% higher than the current stock price, while the lowest is $5.00 (+131.48%) and the highest is $5.51 (+155.09%).

Price Target: $5.26 (+143.52%)

Analyst Consensus: Strong Buy

Price Target

Chart

Target	Low	Average	Median	High
Price	$5.00	$5.26	$5.26	$5.51
Change	+131.48%	+143.52%	+143.52%	+155.09%

Analyst Ratings

The average analyst rating for BioVie stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Chart

Rating	Apr '25	May '25	Aug '25	Nov '25	Jun '26	Jul '26
Strong Buy	1	1	1	1	1	2
Buy	0	0	0	0	0	0
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	1	1	1	1	1	2

Financial Forecast

Revenue This Year

n/a

Revenue Next Year

n/a

EPS This Year

-0.63

from -3.05

EPS Next Year

-0.57

from -0.63

Fiscal Year	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Jun 30, 2022	Jun 30, 2023	Jun 30, 2024	Jun 30, 2025	Jun 30, 2026	Jun 30, 2027
Revenue	-	-	-	-	-	-
Operating Income	-27.25M	-45.08M	-32.18M	-18.07M	-22.65M	-24.20M
Net Income	-26.08M	-50.26M	-32.12M	-17.54M	-22.07M	-23.40M
EPS	-	-	-	-	-3.05	-0.63
Free Cash Flow	-8.77M	-22.84M	-18.78M	-13.13M	-11.12M	-40.88M
No. Analysts	-	-	-	-	-	1

EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Chart

Revenue	2027	2028	2029
High	n/a
Avg	n/a
Low	n/a

Revenue Growth

Chart

Revenue Growth	2028	2029
High	-
Avg	-
Low	-

EPS Forecast

Chart

EPS	2027	2028	2029
High	-0.63
Avg	-0.63
Low	-0.63

EPS Growth

Chart

EPS Growth	2027	2028	2029
High	-
Avg	-
Low	-